![](/img/cover-not-exists.png)
Discussion of Competitive Costs of Disclosure by Biotech IPOs
PAUL HRIBARVolume:
42
Year:
2004
Language:
english
Pages:
8
DOI:
10.1111/j.1475-679x.2004.00141.x
File:
PDF, 59 KB
english, 2004